Correlation Between Trevi Therapeutics and Lantern Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Trevi Therapeutics and Lantern Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Trevi Therapeutics and Lantern Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Trevi Therapeutics and Lantern Pharma, you can compare the effects of market volatilities on Trevi Therapeutics and Lantern Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Trevi Therapeutics with a short position of Lantern Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Trevi Therapeutics and Lantern Pharma.

Diversification Opportunities for Trevi Therapeutics and Lantern Pharma

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Trevi and Lantern is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Trevi Therapeutics and Lantern Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lantern Pharma and Trevi Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Trevi Therapeutics are associated (or correlated) with Lantern Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lantern Pharma has no effect on the direction of Trevi Therapeutics i.e., Trevi Therapeutics and Lantern Pharma go up and down completely randomly.

Pair Corralation between Trevi Therapeutics and Lantern Pharma

Given the investment horizon of 90 days Trevi Therapeutics is expected to generate 0.93 times more return on investment than Lantern Pharma. However, Trevi Therapeutics is 1.07 times less risky than Lantern Pharma. It trades about 0.06 of its potential returns per unit of risk. Lantern Pharma is currently generating about 0.01 per unit of risk. If you would invest  185.00  in Trevi Therapeutics on September 14, 2024 and sell it today you would earn a total of  240.50  from holding Trevi Therapeutics or generate 130.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Trevi Therapeutics  vs.  Lantern Pharma

 Performance 
       Timeline  
Trevi Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Trevi Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Trevi Therapeutics demonstrated solid returns over the last few months and may actually be approaching a breakup point.
Lantern Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Lantern Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, Lantern Pharma is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Trevi Therapeutics and Lantern Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Trevi Therapeutics and Lantern Pharma

The main advantage of trading using opposite Trevi Therapeutics and Lantern Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Trevi Therapeutics position performs unexpectedly, Lantern Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lantern Pharma will offset losses from the drop in Lantern Pharma's long position.
The idea behind Trevi Therapeutics and Lantern Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like